In This Section
FAQs for Clinical Research During the Coronavirus Pandemic
UPDATED December 15, 2020
Please see the December 15, 2020, update of the CHOP Research Institute FAQs for Clinical Research During the Coronavirus Pandemic for important frequently asked research questions related to the staged ramp-up of clinical trials and non-interventional clinical research.
At this time, CHOP Research will continue operating at 75 percent staffing for research groups with six or more people and 100 percent staffing for research groups with fewer than six people, provided appropriate physical (social) distancing can be maintained. Personnel should continue to be encouraged to complete tasks at home whenever possible.
As a reminder, the determination for research staffing percentage is separate from the staged clinical ramp-up. Clinical Research continues to operate in Stage IV. We appreciate your continued flexibility to pivot ramp-up stages based on the COVID-19 pandemic.
Please refer to the PI Protocol Checklist – Return to Clinical Research at CHOP and the updated Subject Research Checklist as additional resources. A patient-family handout Research During COVID-19: Information for Families is also available. A new Monitor/Training Checklist is designed as a tool for study team use when scheduling study monitor/trainer visits.
For questions related to the staged return to clinical research, please contact the Clinical Research Support Office Leadership Team at ClinResearchQuestions [at] email.chop.edu.